Member access

4-Traders Homepage  >  Shares  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

GLAXOSMITHKLINE PLC (GSK)

161
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

GlaxoSmithKline: European Commission Authorizes Nimenix

04/27/2012 | 08:24am US/Eastern

GlaxoSmithKline PLC (>> GlaxoSmithKline plc), the drug company, said Friday that the European Commission has granted marketing authorization for Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, for active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W-135 and Y.

-Shares at 1207 GMT, up a penny, or 0.04%, at 1,420.5 pence valuing the company at GBP71.61 billion.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
React to this article
Latest news on GLAXOSMITHKLINE PLC
1d ago GLAXOSMITHKLINE : Assigned Patent
3d ago LIGAND PHARMACEUTICALS : Partner GlaxoSmithKline Announces EU Regulatory Submiss..
4d ago Exclusive - Takata retains prominent lawyer Levander in air bag scandal
4d ago EXCLUSIVE : Takata retains prominent lawyer Levander in air bag scandal
5d ago GLAXOSMITHKLINE : Medidata Collaborates with GlaxoSmithKline on Mobile Health In..
5d ago GLAXOSMITHKLINE : Glaxo Says Positive Mekinist & Tafinlar Combination Study Publ..
5d ago GLAXOSMITHKLINE : Medidata Joins With GlaxoSmithKline On Mobile Health Initiativ..
5d ago GLAXOSMITHKLINE : GSK leads Access to Medicine Index 2014
11/14 GLAXOSMITHKLINE : Director/PDMR Shareholding- Amendment
11/14 GLAXOSMITHKLINE : GSK launches first call for proposals for research in to non-c..
Advertisement
Chart
Duration : Period :
GlaxoSmithKline plc Technical Analysis Chart | GSK | GB0009252882 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF